Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 1
1969 2
1971 2
1972 1
1973 2
1974 2
1975 3
1976 4
1977 2
1978 5
1979 3
1980 10
1981 8
1982 5
1983 10
1984 5
1985 10
1986 6
1987 10
1988 11
1989 6
1990 9
1991 9
1992 8
1993 15
1994 12
1995 10
1996 11
1997 19
1998 19
1999 13
2000 10
2001 23
2002 11
2003 16
2004 26
2005 21
2006 27
2007 19
2008 18
2009 22
2010 22
2011 27
2012 27
2013 25
2014 29
2015 26
2016 34
2017 26
2018 20
2019 22
2020 28
2021 37
2022 35
2023 28
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

768 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Parathyroid Gland Carcinoma"
Page 1
Parathyroid carcinoma.
Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, de Martino D, Scillitani A, Cole DEC. Salcuni AS, et al. Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):877-889. doi: 10.1016/j.beem.2018.11.002. Epub 2018 Dec 1. Best Pract Res Clin Endocrinol Metab. 2018. PMID: 30551989 Review.
Parathyroid carcinoma (PC) is a rare disease with an indolent behavior due to the low malignant potential. ...Therefore, in patients who carry germline CDC73 gene mutations, its finding permits to identify the carriers among relatives and sometimes to early detect a
Parathyroid carcinoma (PC) is a rare disease with an indolent behavior due to the low malignant potential. ...Therefore, in pa
Parathyroid carcinoma.
Goswamy J, Lei M, Simo R. Goswamy J, et al. Curr Opin Otolaryngol Head Neck Surg. 2016 Apr;24(2):155-62. doi: 10.1097/MOO.0000000000000234. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 26771263 Review.
PURPOSE OF REVIEW: This article highlights recent advances in our understanding of the incidence, epidemiology, clinical presentation, evaluation, diagnosis, treatment, and prognosis of parathyroid carcinoma. RECENT FINDINGS: The prevalence of parathyroid
PURPOSE OF REVIEW: This article highlights recent advances in our understanding of the incidence, epidemiology, clinical presentation, evalu …
Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F, Giusti F, Palmini G, Perigli G, Santoro R, Brandi ML. Marini F, et al. Front Endocrinol (Lausanne). 2022 Feb 24;13:834362. doi: 10.3389/fendo.2022.834362. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282432 Free PMC article. Review.
Parathyroid carcinoma (PC) is an extremely rare malignancy, accounting less than 1% of all parathyroid neoplasms, and an uncommon cause of primary hyperparathyroidism (PHPT), characterized by an excessive secretion of parathyroid hormone (PTH) a
Parathyroid carcinoma (PC) is an extremely rare malignancy, accounting less than 1% of all parathyroid neoplasms
Parathyroid cancer.
Fang SH, Lal G. Fang SH, et al. Endocr Pract. 2011 Mar-Apr;17 Suppl 1:36-43. doi: 10.4158/EP10310.RA. Endocr Pract. 2011. PMID: 21454239 Review.
OBJECTIVE: To review the current knowledge pertaining to the etiology, molecular pathogenesis, and management of parathyroid carcinoma, a rare presentation of primary hyperparathyroidism. METHODS: The existing MEDLINE English-language literature was reviewed using t …
OBJECTIVE: To review the current knowledge pertaining to the etiology, molecular pathogenesis, and management of parathyroid carci
Parathyroid carcinoma.
Givi B, Shah JP. Givi B, et al. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):498-507. doi: 10.1016/j.clon.2010.04.007. Epub 2010 May 26. Clin Oncol (R Coll Radiol). 2010. PMID: 20510594 Free PMC article. Review.
Parathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to 5% of primary hyperparathyroidism cases in various series. ...A significant proportion of patients will experience recurrence, and will need further surgical and, even
Parathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to 5% of primary hyperparathyroidism
Persistent and recurrent hyperparathyroidism.
Guerin C, Paladino NC, Lowery A, Castinetti F, Taieb D, Sebag F. Guerin C, et al. Updates Surg. 2017 Jun;69(2):161-169. doi: 10.1007/s13304-017-0447-7. Epub 2017 Apr 22. Updates Surg. 2017. PMID: 28434176 Review.
The aim of this review is to expose the management of persistent and recurrent hyperparathyroidism. A literature search was performed on MEDLINE using the search terms "recurrent" or "persistent" and "hyperparathyroidism" within the past 10 years. ...A single adenom …
The aim of this review is to expose the management of persistent and recurrent hyperparathyroidism. A literature search was performed …
Neck Procedures: Thyroid and Parathyroid.
Dahiya N, Patel MD, Young SW. Dahiya N, et al. Radiol Clin North Am. 2020 Nov;58(6):1085-1098. doi: 10.1016/j.rcl.2020.07.005. Epub 2020 Sep 17. Radiol Clin North Am. 2020. PMID: 33040850 Review.
Lymph node biopsies can be additionally sampled for thyroglobulin assay to improve sensitivity for detection of recurrent carcinoma. Parathyroid FNA usually involves additional estimation of parathyroid hormone concentration in needle washouts. ...
Lymph node biopsies can be additionally sampled for thyroglobulin assay to improve sensitivity for detection of recurrent carcinom
Parathyroid carcinoma.
Dudney WC, Bodenner D, Stack BC Jr. Dudney WC, et al. Otolaryngol Clin North Am. 2010 Apr;43(2):441-53, xi. doi: 10.1016/j.otc.2010.01.011. Otolaryngol Clin North Am. 2010. PMID: 20510726 Free article. Review.
Parathyroid carcinoma is a rare tumor that is prone to recurrence and poor local-regional control. ...A surgeon's intraoperative analysis is important in managing patients with parathyroid carcinoma. If parathyroid carcinoma is sus
Parathyroid carcinoma is a rare tumor that is prone to recurrence and poor local-regional control. ...A surgeon's intra
Parathyroid carcinoma.
Kebebew E. Kebebew E. Curr Treat Options Oncol. 2001 Aug;2(4):347-54. doi: 10.1007/s11864-001-0028-2. Curr Treat Options Oncol. 2001. PMID: 12057115 Review.
Although parathyroid neoplasms are common and cause primary hyperparathyroidism, parathyroid carcinoma is a rare entity. ...Patients who have persistent or recurrent parathyroid carcinoma should have localizing studies to identify …
Although parathyroid neoplasms are common and cause primary hyperparathyroidism, parathyroid carcinoma is a rare …
Parathyroid carcinoma: Single centre experience.
Cunha C, Pinheiro SL, Donato S, Tavares Bello C, Simões H, Nunes Silva T, Prazeres S, Doutel D, Cavaco BM, Leite V. Cunha C, et al. Clin Endocrinol (Oxf). 2022 Sep;97(3):250-257. doi: 10.1111/cen.14684. Epub 2022 Feb 9. Clin Endocrinol (Oxf). 2022. PMID: 35120263
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism cases. ...CDC73 mutations were present in 38.5% of analysed patients and one patient was diagnosed with MEN1. CONCLUSION: Parathyroid
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism case …
768 results